Patents by Inventor Seishi Suehiro

Seishi Suehiro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6051613
    Abstract: A pharmaceutical composition containing an extract from inflammatory tissue inoculated with vaccinia virus may be used to suppress the death of cells caused by endotoxin, and suppress excessive production of nitrogen monoxide induced by endotoxin. The extract may also be used to relieve hypotension induced by endotoxin. In sepsis and other serious bacterial infectious diseases, endotoxin (an intracellular toxin) is produced and a shock symptom is induced by its action. The extract, having an excellent inhibitory action toward endotoxin-induced toxicity, is quite useful for the treatment or the prevention of endotoxin-induced shock symptoms, sepsis and various symptoms accompanied thereby. In addition, the extract has an inhibitory action towards abnormal nitrogen monoxide production during the diseased state and, therefore, it is also useful as a therapeutic and preventive agent for diseases wherein an excessive nitrogen monoxide production occurs, such as acute hypotension.
    Type: Grant
    Filed: January 5, 1998
    Date of Patent: April 18, 2000
    Assignee: Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Kousaku Ohno, Jin-emon Konishi, Seishi Suehiro
  • Patent number: 5532271
    Abstract: The present invention relates to a method for preventing or treating autoimmune diseases in a mammal which comprises administering to the mammal an effective amount of at least one furanone derivative of the formula (I): ##STR1## wherein X is hydrogen, hydroxy, a lower alkyl group or a lower alkylene group; Y is hydrogen, hydroxy or a lower alkyl group; Z is hydrogen, a lower alkyl group or a lower hydroxyalkyl group; and the broken line represents the presence or absence of a second bond;or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 8, 1994
    Date of Patent: July 2, 1996
    Assignee: Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Mitsuru Naiki, Yuichi Takeoka, Seishi Suehiro
  • Patent number: 5376682
    Abstract: The present invention relates to a method for reducing or treating inflammation in a mammal which comprises administering to the mammal an effective amount of at least one furanone derivative of the formula (I): ##STR1## wherein X is hydrogen, hydroxy, a lower alkyl group or a lower alkylene group; Y is hydrogen, hydroxy or a lower alkyl group; Z is hydrogen, a lower alkyl group or a lower hydroxyalkyl group; and the broken line represents the presence or absence of a second bond; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 25, 1992
    Date of Patent: December 27, 1994
    Assignee: Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Mitsuru Naiki, Yuichi Takeoka, Seishi Suehiro